Omega-3 fatty acids for a better mental state in working populations - Happy Nurse Project: A 52-week randomized controlled trial. (July 2018)

• Record Type: Journal Article
• Authors: Watanabe, Norio; Matsuoka, Yutaka; Kumachi, Mie; Hamazaki, Kei; Horikoshi, Masaru; Furukawa, Toshi A.
• Is Part Of: Journal of psychiatric research. Volume 102(2018)
• Page Start: 72
• Page End: 80
• Publication Date: 2018-07
• Subjects: Anxiety -- Burn out -- Depression -- Fatty acids -- Omega-3 -- Presenteeism; Psychiatry -- Periodicals; Mental Disorders -- Periodicals; Maladies mentales -- Périodiques; Psychiatry; Electronic journals; Periodicals; 616.89005
• DOI: 10.1016/j.jpsychires.2018.03.015
• Languages: English
• ISSNs: 0022-3956

Abstract

Abstract: The efficacy of omega-3 fatty acids for maintaining a better mental state has not been examined among working populations. We aimed to explore the effectiveness of omega-3 fatty acids for hospital nurses. In a multi-center randomized trial, 80 junior nurses were randomly allocated to either omega-3 fatty acids (1200 mg/day of eicosapentaenoic acid and 600 mg/day of docosahexaenoic acid) or identical placebo pills for 13 weeks. The primary outcome was the total score of the Hospital Anxiety and Depression Scale (HADS), determined by a blinded rater at week 26 from the study enrolment. Secondary outcomes included the total score of the HADS at 13 and 52 weeks; incidence of a major depressive episode; severity of depression, anxiety, insomnia, burnout, and presenteeism; utility scores; and adverse events at 13, 26 and 52 weeks. The mean HADS score at baseline was 7.2. At 26 weeks, adjusted mean scores on the HADS were 6.32 (95% CIs of standard errors: 5.13, 7.52) in the intervention and 6.81 (5.57, 8.05) in the placebo groups, respectively. The coefficient of the group by time interaction was not statistically significant at 0.58 (−1.35, 2.50; P = 0.557). Although the intervention group showed significant superiority on the HADS score at 52 weeks, depression severity at 52 weeks, insomnia severity at 13 weeks, and absolute presenteeism at 26 weeks, no significant superiority or inferiority was observed on the other outcomes. The additive value of omega-3 fatty acids was not confirmed regarding mental state and self-evaluated work efficiency. Highlights: The effectiveness of omega-3 PUFAs for prevention of depression was examined. Eighty nurses were randomly allocated to omega-3 or placebo for 13 weeks. Information about depression, anxiety and presenteeism was collected up to 52 weeks. No clinically important difference was comfirmed between two intervention arms.